Frances L. Johnson, MD
July 10, 2013
Frances L. Johnson, MD is a founding member, Acting Chief Executive Officer, and Chief Medical Officer of Viewpoint Molecular Targeting, Inc. Dr. Johnson is a physician scientist and entrepreneur whose experience includes co-founding a biomedical startup (XDx; now CareDx) while faculty at Stanford University. Dr. Johnson completed her undergraduate and graduate degrees in medicine at the University of Washington followed by residency at the University of California San Francisco and fellowship at Stanford University. Dr. Johnson is a primary inventor of the molecular diagnostic technology she developed at Stanford that is a cornerstone of CareDx (market capitalization of $1B). Dr. Johnson remained in academics during the growth phase of CareDx and has led heart transplant teams at three university academic medical centers before co-founding Viewpoint Molecular Targeting with Dr. Schultz and Mr. Coleman. As CEO/CMO at Viewpoint, Dr. Johnson has successfully secured seven Phase I and Phase II National Institutes of Health/National Cancer Institute funded Small Business Innovation Research Grants and Contract Projects ($6M). Dr. Johnson has successfully developed a team that is now set for two IND approvals in 2020.